ABCG2 and lymphoma: In addition, the coexpression of survivin and MRP1/ABCC1 indicates a potential drug-resistant mechanism through the activation of drug efflux pumps as ABC transporters (MRP1/ABCC1 as well as BRCP/ABCG2) and inhibition of lymphoma cell apoptosis.